Reasons for corporate research and development spin‐outs – the chemical and pharmaceutical industry as example
Year: 2014
Type: article
Source: R and D Management
DOI: 10.1111/radm.12077
Author: Gunter Festel
Institutions: ETH Zurich, Technische Universität Berlin
Language: English
Subfield: Accounting
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W1537430929
